We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Headquartered in Torrance, CA, Motorcar Parts of America (MPAA) is a supplier for remanufactured and new parts, which are sold in more than 25,000 outlets in the U.S. and Canada. Its products include starters, alternators, master cylinders, hub assemblies and bearings, brake power boosters, and turbochargers.
Shares Plunge After Weak Results
The company reported adjusted net income of $9.7 million, or $0.50 per diluted share, compared with $12.4 million, or $0.64 per diluted share, in the same period a year earlier. Adjusted EPS also missed the Zacks Consensus Estimate of $0.55.
"The first half of fiscal 2018 was a challenging period, even though we achieved market share gains. As widely reported by industry observers, we are experiencing industry softness and related headwinds,” said the CEO.
Falling Estimates
Analysts have slashed their estimates for the company after weak results. Zacks Consensus Estimates for the current and next fiscal year have fallen to $2.13 per share and $2.49 per share from $2.35 and $2.66 respectively, before the results.
Bottom Line
The stock has fallen to a Zacks Rank #5 (Strong Sell) after weak results. Further, it has Style Scores of “F” for Growth, “C” for both Value and Momentum, and “D” for VGM.
Additionally, the “Automotive - Replacement Parts” industry is currently 241 out 265 Zacks Industries (bottom 9%) suggesting near-term weakness. It’s better to avoid this stock as of now.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Bear of the Day: Motorcar Parts of America (MPAA)
Headquartered in Torrance, CA, Motorcar Parts of America (MPAA) is a supplier for remanufactured and new parts, which are sold in more than 25,000 outlets in the U.S. and Canada. Its products include starters, alternators, master cylinders, hub assemblies and bearings, brake power boosters, and turbochargers.
Shares Plunge After Weak Results
The company reported adjusted net income of $9.7 million, or $0.50 per diluted share, compared with $12.4 million, or $0.64 per diluted share, in the same period a year earlier. Adjusted EPS also missed the Zacks Consensus Estimate of $0.55.
"The first half of fiscal 2018 was a challenging period, even though we achieved market share gains. As widely reported by industry observers, we are experiencing industry softness and related headwinds,” said the CEO.
Falling Estimates
Analysts have slashed their estimates for the company after weak results. Zacks Consensus Estimates for the current and next fiscal year have fallen to $2.13 per share and $2.49 per share from $2.35 and $2.66 respectively, before the results.
Bottom Line
The stock has fallen to a Zacks Rank #5 (Strong Sell) after weak results. Further, it has Style Scores of “F” for Growth, “C” for both Value and Momentum, and “D” for VGM.
Additionally, the “Automotive - Replacement Parts” industry is currently 241 out 265 Zacks Industries (bottom 9%) suggesting near-term weakness. It’s better to avoid this stock as of now.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>